4,4,5,5-Tetramethyl-2-(4-(oxiran-2-ylmethoxy)phenyl)-1,3,2-dioxaborolane, 98%, 1g

Transition piece, 19/26, 29/32, 1 Piece

2-Phenylmorpholine, 95.0%, 10g

(E)-3-(2-Methoxypyridin-3-yl)acrylic acid, 98%, 1g

Methyl 1-methylpiperidine-3-carboxylate, 95.0%, 1g

4'-Methoxybiphenyl-4-carboxylic acid, 98.0%, 10g

D-Lysine, N6-[(1,1-dimethylethoxy)carbonyl]-, 1,1-dimethylethyl ester, hydrochloride (1:1), 97%, 5g

(R)-2-amino-3-(2,3-difluorophenyl)propanoic acid, 98%, 1g

3-Methyl-3-(1H-pyrrol-1-yl)butanoic acid, 95.0%, 250mg

1-(4'-Methyl[1,1'-biphenyl]-2-yl)ethanone, 1g

3-Bromo-6-fluoro-2-methylaniline, 97%, 100mg

3-Bromo-1-methyl-4-nitro-1H-pyrazole, 97.0%, 100mg

3-Cyanopicolinic acid, 95.0%, 250mg